Nasalcrom and Dizziness - a phase IV clinical study of FDA data

Summary:

Dizziness is reported as a side effect among people who take Nasalcrom (cromolyn sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Claritin, and have High blood pressure.

The phase IV clinical study analyzes which people have Dizziness when taking Nasalcrom. It is created by eHealthMe based on reports of 1,489 people who have side effects when taking Nasalcrom from the FDA, and is updated regularly.

What is Nasalcrom?

Nasalcrom has active ingredients of cromolyn sodium. It is often used in allergies. eHealthMe is studying from 1,528 Nasalcrom users. Check the latest studies of Nasalcrom.

What is Dizziness?

Dizziness is found to be associated with 3,570 drugs and 5,711 conditions by eHealthMe. Check the latest studies of Dizziness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 15, 2026

1,489 people reported to have side effects when taking Nasalcrom.
Among them, 49 people (3.29%) have Dizziness.

Among these 49 people:

How long have people been on Nasalcrom when they have Dizziness? *

What is the gender of people who have Dizziness when taking Nasalcrom? *

female: 75.51 %
male: 24.49 %

What is the age of people who have Dizziness when taking Nasalcrom? *

What are other drugs people take besides Nasalcrom? *

What are other side effects people have besides Dizziness? *

Dyspnea (difficult or laboured breathing): 21 people, 42.86%
Headache (pain in head): 19 people, 38.78%
Fatigue (feeling of tiredness): 19 people, 38.78%
Feeling Abnormal: 17 people, 34.69%
Chest Pain: 17 people, 34.69%
Hypersensitivity: 16 people, 32.65%
High Blood Pressure: 16 people, 32.65%
Tremor (trembling or shaking movements in one or more parts of your body): 15 people, 30.61%
Stress And Anxiety: 14 people, 28.57%
Constipation: 14 people, 28.57%

What are the existing conditions these people have? *

High Blood Pressure: 15 people, 30.61%
Hypersensitivity: 13 people, 26.53%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 12 people, 24.49%
Ill-Defined Disorder: 12 people, 24.49%
Thrombosis (formation of a blood clot inside a blood vessel): 8 people, 16.33%
Constipation: 7 people, 14.29%
Stress And Anxiety: 7 people, 14.29%
Asthma: 7 people, 14.29%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 10.20%
Pain: 4 people, 8.16%

* Approximation only. Some reports may have incomplete information.

Do you take Nasalcrom and have Dizziness?

- Check whether Dizziness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nasalcrom:

Nasalcrom (1,528 reports)

Dizziness treatments and more:

Dizziness (613,962 reports)

Browse all side effects of Nasalcrom:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dizziness:

Dizziness (3,570 drugs)

Browse all the conditions that are associated with Dizziness:

Dizziness (5,711 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cromolyn sodium (the active ingredients of Nasalcrom) and Nasalcrom (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.